Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
Advances in Medicine · 14.03.2023 · 2023 · 1-10
DOI: 10.1155/2023/5060665 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Medicine, erschienen am 14.03.2023. Verfasst von Swaroop Kumar Pandey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malaria continued to be a deadly situation for the people of tropical and subtropical countries. Although there has been a marked reduction in new cases as well as mortality and morbidity rates in the last two decades, the reporting of malaria caused 247 million cases and 619000 deaths worldwide in 2021, according to the WHO (2022). The development of drug resistance and declining efficacy against most of the antimalarial drugs/combination in current clinical practice is a big challenge for the scientific community, and in the absence of an effective vaccine, the problem becomes worse. Experts from various research organizations worldwide are continuously working hard to stop this disaster by employing several strategies for the development of new antimalarial drugs/combinations. The current review focuses on the history of antimalarial drug discovery and the advantages, loopholes, and opportunities associated with the common strategies being followed for antimalarial drug development.
Autor:innen und Institutionen
- Department of Life Sciences, The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
- Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
- Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh 202001, Uttar Pradesh, India.
- Department of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Lucknow 226031, Uttar Pradesh, India.
ORCID-Profile: Swaroop Kumar Pandey, Uttpal Anand
Zitieren
APA
Pandey, S. K., Anand, U., Siddiqui, W. A., & Tripathi, R. (2023). Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update. Advances in Medicine, 2023, 1-10. https://doi.org/10.1155/2023/5060665
Vancouver
Pandey SK, Anand U, Siddiqui WA, Tripathi R. Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update. Advances in Medicine. 2023;2023:1-10. doi:10.1155/2023/5060665
BibTeX
@article{Pandey2023,
author = {Pandey, Swaroop Kumar and Anand, Uttpal and Siddiqui, Waseem A and Tripathi, Renu},
title = {Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update},
journal = {Advances in Medicine},
year = {2023},
volume = {2023},
pages = {1--10},
doi = {10.1155/2023/5060665}
}
EUVIMED